Accord Aims At Addiction With Buprenorphine Implant Deal
Agreement Sees Firm Distribute Sixmo For Molteni Farmaceutici In Europe
Accord is kicking off plans to launch a number of addiction treatments by partnering with Molteni Farmaceutici on distributing its Sixmo six-month buprenorphine implant in Europe.
